| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-85 |
Sentence |
denotes |
Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer. |
| T1 |
0-85 |
Sentence |
denotes |
Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer. |
| TextSentencer_T2 |
86-231 |
Sentence |
denotes |
Previous reports have shown that Her-2/neu oncogene expression in human breast cancer and ovarian cancer may be associated with poorer prognosis. |
| T2 |
86-231 |
Sentence |
denotes |
Previous reports have shown that Her-2/neu oncogene expression in human breast cancer and ovarian cancer may be associated with poorer prognosis. |
| TextSentencer_T3 |
232-370 |
Sentence |
denotes |
We report the expression of Her-2/neu on fresh samples of known prostatic adenocarcinoma but not on those of benign prostatic hypertrophy. |
| T3 |
232-370 |
Sentence |
denotes |
We report the expression of Her-2/neu on fresh samples of known prostatic adenocarcinoma but not on those of benign prostatic hypertrophy. |
| TextSentencer_T4 |
371-580 |
Sentence |
denotes |
Using a monoclonal antibody (TA1) directed against human Her-2/neu oncogene product and an immunohistochemical staining method, no Her-2/neu expression was noted with benign prostatic hypertrophy (15 samples). |
| T4 |
371-580 |
Sentence |
denotes |
Using a monoclonal antibody (TA1) directed against human Her-2/neu oncogene product and an immunohistochemical staining method, no Her-2/neu expression was noted with benign prostatic hypertrophy (15 samples). |
| TextSentencer_T5 |
581-674 |
Sentence |
denotes |
With prostatic adenocarcinoma samples, a subset (9 of 25) showed overexpression of Her-2/neu. |
| T5 |
581-674 |
Sentence |
denotes |
With prostatic adenocarcinoma samples, a subset (9 of 25) showed overexpression of Her-2/neu. |
| TextSentencer_T6 |
675-826 |
Sentence |
denotes |
Such overexpression is correlated with higher histological grade, higher stage of disease, and high S phase and aneuploidy on flow cytometric analysis. |
| T6 |
675-826 |
Sentence |
denotes |
Such overexpression is correlated with higher histological grade, higher stage of disease, and high S phase and aneuploidy on flow cytometric analysis. |
| TextSentencer_T7 |
827-919 |
Sentence |
denotes |
These findings suggest that Her-2/neu may be a prognostic marker in prostate cancer as well. |
| T7 |
827-919 |
Sentence |
denotes |
These findings suggest that Her-2/neu may be a prognostic marker in prostate cancer as well. |
